PAMELA HARRINGTON: Open Payments
NPI 1871511923 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 19 payments from 11 companies in 2025. Trend: 2023 $1,499 · 2024 $1,619 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $460 |
| AstraZeneca Pharmaceuticals LP | 4 | $406 |
| Insmed, Inc. | 2 | $262 |
| Gilead Sciences, Inc. | 1 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| GENZYME CORPORATION | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| Verona Pharma, Inc. | 1 | $114 |
Products named: Arikayce, Wegovy, BREZTRI, Ozempic, Biktarvy, Kerendia, DUPIXENT, TZIELD.
Industry payments across FL — which companies pay providers there.
